Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[The role of dopamine in the regulation of the interaction between nervous and immune systems in multiple sclerosis.]
Cortical Pathology in RRMS: Taking a Cue from Four Sisters.
Role of metabotropic glutamate receptor 5 signaling and homer in oxygen glucose deprivation-mediated astrocyte apoptosis.
The role of complement in neurological and neuropsychiatric diseases.
Seronegative neuromyelitis optica presenting with life-threatening respiratory failure.
Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.
Co-Existence of Familial Mediterranean Fever and Multiple Sclerosis in Two Patients.
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.
Tetrahydrocannabinol
Immune-mediated disorders among women carriers of fragile X premutation alleles.
Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging.
Lymphocytes with cytotoxic activity induce rapid microtubule axonal destabilization independently and before signs of neuronal death.
Adapted Resistance Training Improves Strength in Eight Weeks in Individuals with Multiple Sclerosis.
Smokers run increased risk of developing anti-natalizumab antibodies.
Smoking and inflammation: evidence for a synergistic role in chronic disease.
Statistical normalization techniques for magnetic resonance imaging.
OPtimizing CNS drug development using molecular imaging.
B lymphocytes in neuromyelitis optica.
Psychosocial, Affective, and Behavioral Consequences of Multiple SclerosisTreatment of the "Whole" Patient.
JC Polyomavirus Infection Is Strongly Controlled by Human Leucocyte Antigen Class II Variants.
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Does natalizumab therapy worsen neuromyelitis optica?
Further validation of Multiple Sclerosis Walking Scale-12 scores based on spatiotemporal gait parameters.
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »